SEC Form 4 research
| Issuer | Capstone Therapeutics Corp. |
|---|---|
| Tickers | CAPS, OLGC |
| Reporting owners | 28 |
| Officers and directors | 11 |
| Last public filing | 2026-08-12 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-11 | 2026-08-07 | FELDMAN FREDRIC J | A | 105,124 | Not reported | Not reported |
| 2026-08-11 | 2026-03-30 | FELDMAN FREDRIC J | A | 95,000 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | Grotke Kevin Allan | A | 515,495 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | HOLLIMAN JOHN M III | A | 305,248 | Not reported | Not reported |
| 2026-08-11 | 2026-03-30 | HOLLIMAN JOHN M III | A | 95,000 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | HOWSE ELWOOD D | A | 105,124 | Not reported | Not reported |
| 2026-08-11 | 2026-03-30 | HOWSE ELWOOD D | A | 95,000 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | Lipman Matthew E. | A | 1,094,648 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | SCHULTZ EDWARD CHRISTOPHER | A | 310,310 | Not reported | Not reported |
| 2026-08-11 | 2026-08-07 | Strout Gordon Lewis Jr | A | 357,810 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.